EUVIMEDEUVIMED entdecken
Crossref

Aprotinin does not Impair Vascular Function in Patients Undergoing Coronary Artery Bypass Graft Surgery

Josephine Tolkmitt, Heike Brendel, Birgit Zatschler, Stefan Brose, Coy Brunssen, Irakli Kopaliani, Andreas Deussen, Klaus Matschke, Henning Morawietz

Hormone and Metabolic Research · 01.01.2023 · 55 (01) · 65-74

DOI: 10.1055/a-1984-0255 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.01.2023. Verfasst von Josephine Tolkmitt und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine III, Division of Vascular Endothelium and Microcirculation, Technische Universität Dresden, Dresden, Germany. Hauptthemen laut MEDLINE: Aprotinin, Nitric Oxide Synthase Type III. Die Arbeit nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bleeding is a major complication in coronary artery bypass graft surgery. Antifibrinolytic agents like serine protease inhibitor aprotinin can decrease postoperative bleeding and complications of cardiac surgery. However, the effects of aprotinin on vascular function are not completely elucidated. We compared the ex vivo vascular function of left internal mammary arteries from patients undergoing coronary artery bypass graft surgery with and without intraoperative application of aprotinin using a Mulvany Myograph. Human internal mammary arteries were treated with aprotinin ex vivo and tested for changes in vascular function. We analyzed the impact of aprotinin on vascular function in rat aortic rings. Finally, impact of aprotinin on expression and activity of endothelial nitric oxide synthase was tested in human endothelial cells. Intraoperative application of aprotinin did not impair ex vivo vascular function of internal mammary arteries of patients undergoing coronary artery bypass graft surgery. Endothelium-dependent and -independent relaxations were not different in patients with or without aprotinin after nitric oxide synthase blockade. A maximum vasorelaxation of 94.5%±11.4vs. 96.1%±5.5% indicated a similar vascular smooth muscle function in both patient groups (n=13 each). Long-term application of aprotinin under physiological condition preserved vascular function of the rat aorta. In vitro application of increasing concentrations of aprotinin on human endothelial cells resulted in a similar expression and activity of endothelial nitric oxide synthase. In conclusion, intraoperative and ex vivo application of aprotinin does not impair the endothelial function in human internal mammary arteries and experimental models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AprotininNitric Oxide Synthase Type IIIHumansRatsAnimalsEndothelial CellsCoronary Artery BypassSerine Proteinase Inhibitors

Substanzen

AprotininNitric Oxide Synthase Type IIISerine Proteinase Inhibitors

Autor:innen und Institutionen

  • Department of Medicine III, Division of Vascular Endothelium and Microcirculation, Technische Universität Dresden, Dresden, Germany.
  • Institute of Physiology, Technische Universität Dresden, Dresden, Germany.
  • Department of Cardiac Surgery, University Heart Center Dresden, Technische Universität Dresden, Dresden, Germany.
  • Division of Vascular Endothelium and Microcirculation, Technische Universität Dresden, Dresden, Germany.

Zitieren

APA

Tolkmitt, J., Brendel, H., Zatschler, B., Brose, S., Brunssen, C., Kopaliani, I., Deussen, A., Matschke, K., & Morawietz, H. (2023). Aprotinin does not Impair Vascular Function in Patients Undergoing Coronary Artery Bypass Graft Surgery. Hormone and Metabolic Research, 55(01), 65-74. https://doi.org/10.1055/a-1984-0255

Vancouver

Tolkmitt J, Brendel H, Zatschler B, Brose S, Brunssen C, Kopaliani I, et al. Aprotinin does not Impair Vascular Function in Patients Undergoing Coronary Artery Bypass Graft Surgery. Hormone and Metabolic Research. 2023;55(01):65-74. doi:10.1055/a-1984-0255

BibTeX
@article{Tolkmitt2023,
  author = {Tolkmitt, Josephine and Brendel, Heike and Zatschler, Birgit and Brose, Stefan and Brunssen, Coy and Kopaliani, Irakli and Deussen, Andreas and Matschke, Klaus and Morawietz, Henning},
  title = {Aprotinin does not Impair Vascular Function in Patients Undergoing Coronary Artery Bypass Graft Surgery},
  journal = {Hormone and Metabolic Research},
  year = {2023},
  volume = {55},
  number = {01},
  pages = {65--74},
  doi = {10.1055/a-1984-0255}
}
Kostenlos starten →